CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 22,429 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 11,378 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Research & Development gave up 11,313 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 38,450 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 28,366 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 16,344 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 1,214 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 39,132 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 12,713 shares (to pay taxes)
- 4 Shares withheld for taxes Section 16 gave up 6,048 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 3,800 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
Page 2 of 38 · 752 filings